Radiology Business May 17, 2024
Marty Stempniak

Private equity dealmaking in healthcare has stalled in 2024 amid a persistent bid-ask gap, a “decidedly negative” regulatory environment and signals interest rates will remain high for the foreseeable future.

That’s according to a new report from data firm Pitchbook, published earlier this month. Private equity healthcare sponsors announced or closed about 158 deals in the first quarter (including five in imaging), a “downward trend even from 2023’s sluggish pace.” During the same three months last year, PE healthcare services investors closed 200 transactions, representing a 20% year-over-year drop.

However, more sponsors are at least looking to deploy capital, with financing easier to come by than mid-2023, wrote Rebecca Springer, PhD, lead analyst in healthcare for Pitchbook.

“Firms have deals...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Mergers & Acquisitions / JV, Survey / Study, Trends
Pricing Strategy for Startups
Top 10 healthcare IT deals in Q1
Plenful picks up $17M for pharmacy workflow automation
Healthcare payments firm Waystar plans $1B IPO
Plenful Secures $17M to Scale AI-Powered Pharmacy Operations Tool

Share This Article